David Evan Leaf

Brigham and Women's Hospital

NIH Rank #3328
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.6M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#3,328
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.6M across 4 grants · National rank #3328.

Top grants by award amount

David Evan Leaf's NIH grant portfolio, ranked by award amount.

  • 1U01AG089040-01U01
    Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery Bypass
    $1M
    award amount
  • 5R01DK126685-03R01
    Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney Injury
    $733.3K
    award amount
  • 5R01DK125786-05R01
    Deferoxamine for the Prevention of Acute Kidney Injury
    $712.5K
    award amount
  • 3R01DK126685-03S1R01
    Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney Injury
    $165.1K
    award amount

Affiliation

Institutions that have administered grants for David Evan Leaf.

Affiliated with Brigham and Women's Hospital (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3328
  6. 2024
    Entered Top 25% Nationally
    Ranked #3328